JPH01296982A - Culture method for hepatic cell - Google Patents

Culture method for hepatic cell

Info

Publication number
JPH01296982A
JPH01296982A JP63127023A JP12702388A JPH01296982A JP H01296982 A JPH01296982 A JP H01296982A JP 63127023 A JP63127023 A JP 63127023A JP 12702388 A JP12702388 A JP 12702388A JP H01296982 A JPH01296982 A JP H01296982A
Authority
JP
Japan
Prior art keywords
culture
cells
hepatocytes
cultured
hepatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63127023A
Other languages
Japanese (ja)
Inventor
Norio Koide
小出 典男
Kuniyo Inoue
國世 井上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tosoh Corp
Original Assignee
Tosoh Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tosoh Corp filed Critical Tosoh Corp
Priority to JP63127023A priority Critical patent/JPH01296982A/en
Publication of JPH01296982A publication Critical patent/JPH01296982A/en
Pending legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PURPOSE:To provide the title culture method in such a manner that hepatocytes are put to culture under specified conditions, and using the resultant culture solution separated, hepatic cells are subjected to culture for a long period in such a state as to be suspended in a spherically aggregated form, while retaining stabilized functions and form. CONSTITUTION:Hepatocytes are put to culture in a negative electric charge-free plastic container, using a serumless medium absent from any substrate for cell adhesion and interstitial matter out of hepatic cell, and the resultant cells are separated by, e.g., ultrafiltration to prepare a culture solution. Thence, a spherical cluster of hepatic cell is added to said culture solution to make a culture of the hepatic cells.

Description

【発明の詳細な説明】 (産業上の利用分野) 肝細胞はアルブミン、フィブリノーゲンなどの多種の蛋
白質の生合成を行なったり、解毒などの非常に複雑な代
謝機能を有している細胞である。
[Detailed Description of the Invention] (Industrial Application Field) Hepatocytes are cells that perform biosynthesis of various proteins such as albumin and fibrinogen, and have extremely complex metabolic functions such as detoxification.

この肝細胞の培養系を確立することはこれらの生体にと
って重要な種々の機能をin vitroで再現するこ
とを可能にする。すなわち、未だ不明な肝細胞の機能を
明らかにするためのモデルを提供し、細胞生物学の主要
な研究手法として数多く利用されるものであり、薬物な
どの種々の物質の毒性試験においても、生体を用いるこ
となく in vitroの系で行うことを可能にする
ものである。
Establishing this hepatocyte culture system makes it possible to reproduce in vitro various functions important to these living organisms. In other words, it provides a model for elucidating the still unknown functions of liver cells, and is widely used as a major research method in cell biology. This makes it possible to perform this in an in vitro system without using.

さらに、生物学的人工肝臓として、前記の多種多様の機
能を代行しうる人工的肝補助の装置作製に対して大きな
期待を抱かせるものである。
Furthermore, there are great expectations for the production of an artificial liver support device that can perform the various functions described above as a biological artificial liver.

本発明は長期間の安定した機能を持つ肝細胞の培養方法
に関するものである。
The present invention relates to a method for culturing hepatocytes that have stable functions over a long period of time.

(従来の技術) 培養肝細胞の生物活性を左右するものとして多(の原因
が考えられるが、なかでも血清因子と培1重基質か重要
とされている。血清因子としては、インシュリン、上皮
成長因子などの各種ホルモンが肝細胞の生着、増殖に重
要な役割を果たしていることが知られている。しかし、
血清中のその他の多くの因子が肝細胞の長期生存に及ぼ
す効果については一定の見解がなく検討を要する。培養
基質としては、コラーゲンや接合蛋白の他、これ等が複
合体を形成している細胞外間質物質が知られている。
(Prior art) There are many possible causes that influence the biological activity of cultured hepatocytes, but serum factors and medium single-layer substrate are considered to be particularly important. Serum factors include insulin, epithelial growth, It is known that various hormones such as factors play an important role in the engraftment and proliferation of hepatocytes.
There is no consensus on the effects of many other factors in serum on the long-term survival of hepatocytes, and further investigation is required. In addition to collagen and junction proteins, extracellular interstitial substances in which these materials form complexes are known as culture substrates.

従来は、成熟動物の肝臓をコラゲナーゼかん流法により
肝細胞を分離して、コラーゲンや接合蛋白基質上で行う
単層培養が頻用されている。また、初代培養用容器によ
る初代培養法も行われている。
Conventionally, hepatocytes are separated from the liver of an adult animal by a collagenase perfusion method, and monolayer culture is often used on a collagen or junctional protein substrate. In addition, a primary culture method using a primary culture container is also used.

さらに、自己増殖能を持った継代培養細胞も用いられて
いる。
Furthermore, subcultured cells with self-propagation ability are also used.

(発明が解決しようとする課題) 従来繁用されている初代肝細胞の単層培養法につい−C
は長期にわたる機能維持については問題点が多い。つま
り、アルブミン等の分泌物質の生合成、分泌量が生体内
でのそれに比較して非常に低値を示すからである。
(Problem to be solved by the invention) Regarding the conventionally frequently used monolayer culture method of primary hepatocytes-C
There are many problems with long-term functional maintenance. In other words, the biosynthesis and secretion amount of secreted substances such as albumin are extremely low compared to those in vivo.

また、血清添加培地中で培養を行なった場合、実質細胞
は1週間で死滅し、それに代わって非実質細胞の出現が
起こり、長期間の培養は不可能である。
Furthermore, when culture is performed in a serum-supplemented medium, parenchymal cells die within one week and non-parenchymal cells appear in their place, making long-term culture impossible.

長期間培養するには形質転換を起こしていわゆるガン化
した肝細胞を用いれば継代できて目的にかなうが、正常
の肝細胞が本来持つ分化機能を喪失している場合が多く
、機能維持には大きな疑問点か残る。
For long-term culture, it is possible to subculture cells that have undergone transformation and become cancerous, which serves the purpose, but in many cases, they have lost the differentiation function that normal hepatocytes have, and it is difficult to maintain the function. remains a big question mark.

肝細胞外間質物質を培養基質として、無血清培地中で培
養するなどによっても、細胞が球状に集合し浮遊した形
態をとり、2週間培養可能であり、培養液中へのアルブ
ミン、トランスフェリン、フィブリノーゲン等の蛋白質
の分泌が確認され、2週間その分泌口はin vivo
のレベルを維持することができる。しかし、この肝細胞
外間質物質を得るにはtSl!>Vな操作を要する。
By culturing in a serum-free medium using hepatic extracellular interstitial material as a culture substrate, the cells aggregate into a spherical shape and take on a floating form, which can be cultured for two weeks.Albumin, transferrin, and The secretion of proteins such as fibrinogen was confirmed, and the secretion port remained in vivo for two weeks.
can maintain the level of However, to obtain this hepatic extracellular interstitial material, tSl! >V operation is required.

[課題を解決するための手段] 以」二のような問題点を解決すべく、本発明者らは鋭意
検討した結果、比較的長期間培養が可能であり、細胞は
球状に集合して浮遊し、形態的にも、またアルブミン等
の蛋白質分泌能などの機能的にも生体内のそれに等しく
維持でき、操作としては簡便な培養方法を確立した。
[Means for Solving the Problems] In order to solve the problems mentioned above, the present inventors have made extensive studies and found that it is possible to culture for a relatively long period of time, and cells aggregate in a spherical shape and float. However, we have established a culture method that maintains the same morphology and function as in vivo, such as the ability to secrete proteins such as albumin, and is easy to operate.

すなわち本発明は、肝臓より分離した肝実質細胞を、陰
性荷電を持たないプラスチック製の培養容器中で、細胞
接着のための基質及び肝細胞外間質物質を添加せずに、
無血清培地を用いて培養した培養液に肝細胞球状塊を添
加して培養することを特徴とする肝細胞の培養方法、及
び、肝臓より分離した肝実質細胞を、陰性荷電を持たな
いプラスチック製の培養容器中で、細胞接着のための基
質及び肝細胞外間質物質を添加せずに、無血清培地を用
いて培養した培養容器に肝細胞球状塊を添加して培養す
ることを特徴とする肝細胞の培養方法を提供する。以下
本発明の詳細な説明する。
That is, in the present invention, hepatic parenchymal cells separated from the liver are cultured in a non-negatively charged plastic culture vessel without adding a substrate for cell adhesion or extrahepatic interstitial material.
A method for culturing hepatocytes characterized by adding hepatocyte spherules to a culture medium cultured using a serum-free medium, and a method for culturing hepatocytes separated from the liver using a non-negatively charged plastic material. The method is characterized in that hepatocyte spherules are added and cultured in a culture container that has been cultured using a serum-free medium without adding a substrate for cell adhesion or an extrahepatic interstitial substance. The present invention provides a method for culturing hepatocytes. The present invention will be explained in detail below.

肝細胞球状塊を培養するための培養液又は培養容器は、
本発明者らが昭和63年4月30日付特許出願した「肝
細胞の球状培養方法」に従って培養し、香られた培養液
または培養容器を用いればよい。
The culture solution or culture container for culturing hepatocyte spherules is
The cells may be cultured in accordance with the "Method for spherical culture of hepatocytes" for which the present inventors filed a patent application dated April 30, 1986, and a scented culture solution or culture vessel may be used.

即ち、肝細胞は、成熟動物の新鮮な肝臓から無傷の肝実
質細胞を得ればよく、その手法については特に限定しな
い。例えば、動物を麻酔下に開腹し、門脈内にカニユー
レを挿入し、前がん流した後0.05%コラゲナーゼ液
によりかん流して肝細胞を分散し、低速遠心により実質
細胞を分離することができる。
That is, hepatocytes may be obtained from intact hepatic parenchymal cells from the fresh liver of an adult animal, and the method is not particularly limited. For example, the animal is laparotomyd under anesthesia, a cannula is inserted into the portal vein, precancerous cells are flushed out, hepatocytes are dispersed by perfusion with 0.05% collagenase solution, and parenchymal cells are separated by low-speed centrifugation. I can do it.

使用する無血清培地は、通常動物細胞の初代培養に用い
られているものを用いれば良い。具体的には、ウィリア
ム メディウムEにインシュリンl口μg/Φ1.グル
カゴンlOμg/m1.上皮成長因子501g/ll、
プロラクチン20iLl/+Ill、成長ホルモン10
uU/1、銅0.1 μ間、セレニウム3μM、亜鉛5
0pMを添加した無血清培地などを例示することができ
る。
The serum-free medium used may be one that is normally used for primary culture of animal cells. Specifically, insulin was added to William Medium E in μg/Φ1. Glucagon lOμg/ml. Epidermal growth factor 501g/ll,
Prolactin 20iLl/+Ill, growth hormone 10
uU/1, copper 0.1μ, selenium 3μM, zinc 5
For example, a serum-free medium supplemented with 0 pM may be used.

培養容器は、基材として陰性荷電を持たないプラスチッ
ク製のものを用いてコラーゲン等の細胞接7′jのため
の基質を塗布していないものであれば良い。具体的には
、ファルコン組織培養デイツシュ、ファルコンペトリデ
ィッシュ、ブライマリアデイツシュ(ベクトン&ディッ
キントン社製)。
The culture container may be one that is made of plastic that does not have a negative charge as a base material and is not coated with a substrate for cell contact 7'j such as collagen. Specifically, Falcon Tissue Culture Dish, Falcon Petri Dish, and Brimaria Dish (manufactured by Becton & Dickington).

コースタ−デイツシュ(データ・パッケージング社製)
、住友ベークライト細胞培養用シャーレ(住友ベークラ
イト(株)製)等を例示することができる。
Coaster dates (manufactured by Data Packaging)
, Sumitomo Bakelite cell culture petri dish (manufactured by Sumitomo Bakelite Co., Ltd.), and the like.

以上記したものを用いて培養を行って培養液又は培養容
器を得る。この培養は公知の方法で炭酸ガスインキュベ
ーター内で行えば良い。培養する細胞の初濃度はLO5
個/ll11から106個/mlまでの範囲が望ましい
。培養時間は、予めその培養液によって肝細胞を培養し
て良好な結果を与えることで決定すれば良く、特に限定
はない。本発明者らの検討によれば、培養液を得る場合
は、数時間、好ましくは3.4時間培養すればよい。ま
た培養容器を得る場合は、数日、好ましくは4日以上培
養すればよい。
Culture is performed using the materials described above to obtain a culture solution or a culture container. This culture may be performed in a carbon dioxide incubator using a known method. The initial concentration of cells to be cultured is LO5
A range of 11 to 106 cells/ml is desirable. The culture time may be determined in advance by culturing hepatocytes with the culture solution to obtain good results, and is not particularly limited. According to studies by the present inventors, when obtaining a culture solution, it is sufficient to culture for several hours, preferably 3.4 hours. Moreover, when obtaining a culture container, the culture may be carried out for several days, preferably for 4 days or more.

このような培養後、限外濾過、遠心分離などにより■1
1胞を除去した培養液又は培養液、細胞を除去した培養
容器を用いて肝細胞球状塊を添加し、培養する。培養液
を用いて培養を行う場合、その容器には種々のものが使
用でき、特に限定はない。
After such culturing, ■1 by ultrafiltration, centrifugation, etc.
A hepatocyte spherical mass is added and cultured using a culture medium or a culture medium from which one cell has been removed and a culture vessel from which cells have been removed. When culturing is carried out using a culture solution, various types of containers can be used, and there are no particular limitations.

また、培養容器を用いて培養を行う場合、培養液は、通
常動物細胞の初代培養に用いられる無血清培地でよく、
特別な基質を添加する必要はない。
In addition, when culturing is performed using a culture container, the culture solution may be a serum-free medium that is usually used for primary culture of animal cells.
There is no need to add special substrates.

このようにして得られた培養液、培養容器のいずれかを
用いて肝細胞球状塊の培養を行う。肝細胞球状塊とは、
肝細胞が球状に集合して浮遊した細胞塊を意味する。こ
の細胞塊を得る方法については、特に限定しない。−例
として、本発明者らが行った昭和63年4月30日付特
許出願「肝細胞の球状培養方法」に従って肝細胞を培養
し、肝細胞球状塊を得るなどがあげられる。具体的には
、陰性荷電を持たないプラスチック製の培養容器を用い
て先に示した方法と同一条件で4日間培養するとこの細
胞塊が形成されるので、これを培養液と共に回収して低
速遠心によってそれまでの培養液と分離することによっ
て得ることができる。
The hepatocyte spherical mass is cultured using either the culture solution or culture container thus obtained. What is hepatocyte spheroid?
It refers to a cell mass in which hepatocytes aggregate in a spherical shape and float. There are no particular limitations on the method for obtaining this cell mass. - For example, hepatocytes may be cultured in accordance with the patent application filed by the present inventors on April 30, 1986 entitled "Method for culturing spherical hepatocytes" to obtain spherical hepatocyte masses. Specifically, if a plastic culture container with no negative charge is used and cultured for 4 days under the same conditions as described above, this cell mass will be formed, which will be collected together with the culture medium and subjected to low-speed centrifugation. It can be obtained by separating it from the previous culture solution.

最終的に目的とする肝細胞球状塊の培養は、培養環境、
細胞数については公知の方法を用いれば良く、特に限定
はないが、例えば、37℃の5%CO2インキュベータ
ー内で培養すればよい。
The final goal of culturing hepatocyte spherules requires a culture environment,
Regarding the number of cells, any known method may be used, and there is no particular limitation, but for example, the cells may be cultured in a 5% CO2 incubator at 37°C.

(作用) 肝細胞球状塊が浮遊した状態で長時間培養が可能となる
理由は、肝細胞球状塊の培養に用いた培養液又は培養容
器に、先に培養した肝細胞からプロテオグリカンが分泌
されたためと考えられる。
(Effect) The reason why hepatocyte spherules can be cultured in a suspended state for a long time is because proteoglycans were secreted from the previously cultured hepatocytes into the culture medium or culture container used for culturing the hepatocyte spherules. it is conceivable that.

(発明の効果) 本発明により、安定した機能及び形態を待つ肝細胞を、
球状に集合して浮遊した状態で長期間の培養が可能であ
る。
(Effect of the invention) According to the present invention, hepatocytes that are waiting for stable function and morphology,
Long-term culture is possible in a spherical, floating state.

また肝細胞培養液を用いて肝細胞球状塊の培養を行う場
合は、同じ培養液をくり返して用いることができ、その
時の容器には特に限定はなく、通常の方法で簡便に培養
することができる。培養後の容器を用いて肝細胞球状塊
を培養する場合は、培養液は通常用いられているものが
使用でき、特別な基質を添加する必要がなく、簡便に培
養することができる。
In addition, when culturing hepatocyte spherules using a hepatocyte culture medium, the same culture medium can be used repeatedly, and there are no particular limitations on the container used, and the culture can be easily carried out using normal methods. can. When culturing hepatocyte spherules using a container after culturing, a commonly used culture solution can be used, and there is no need to add a special substrate, and the culture can be carried out easily.

(実施例) 以下、本発明を実施例にてさらに詳細に説明するが、本
発明はこれら実施例に限定されるものではない。
(Examples) Hereinafter, the present invention will be explained in more detail with reference to Examples, but the present invention is not limited to these Examples.

実施例1 200〜250gの成熟ラットをネンブタール麻酔下に
開腹し、肝臓門脈内に挿入したカニユーレよりカルシウ
ムイオンを含まないハンクス液で前がん流を行った。0
.05%コラゲナーゼ液により6〜8分かん流を行った
。その後肝細胞は分散させ分離して50Xg、1分間の
低速遠心を3回行って非実質細胞を除去した。ウィリア
ム メディウムEにインシλリンIOμg/a I 、
グルカゴンIOμg/m I 、上皮成長因子50ng
/ml、プロラクチン2011111011 、成長ホ
ルモンlOμU/m1.銅0゜■μM、セレニウム3μ
M、亜鉛509Mを添加した無血清培地(以下HDMと
略す)61あたりに上記の肝細胞5XlO’個を浮遊さ
せ、これをプライマリアポトル(ベクトン&ディッキン
ソン社製)内で4時間炭酸ガス5%に調節した37℃の
炭酸ガスインキュベーター内で培養した。培養後の培養
上清を回収して低速遠心後、全細胞を除去した。
Example 1 Adult rats weighing 200 to 250 g were subjected to laparotomy under Nembutal anesthesia, and precancerous flow was performed using Hank's solution containing no calcium ions through a cannula inserted into the hepatic portal vein. 0
.. Perfusion was performed for 6 to 8 minutes with 0.05% collagenase solution. Thereafter, the hepatocytes were dispersed and separated, and non-parenchymal cells were removed by low-speed centrifugation at 50×g for 1 minute three times. William Medium E with insulin IO μg/a I,
Glucagon IO μg/m I, epidermal growth factor 50 ng
/ml, prolactin 2011111011, growth hormone lOμU/ml. Copper 0゜■μM, selenium 3μ
M, 5XlO' of the above hepatocytes were suspended in a serum-free medium (hereinafter abbreviated as HDM) 61 supplemented with 509M zinc, and incubated with 5% carbon dioxide gas for 4 hours in Primary Apotol (manufactured by Becton & Dickinson). The cells were cultured in a carbon dioxide gas incubator at 37°C. After culturing, the culture supernatant was collected and centrifuged at low speed, and all cells were removed.

同様にして得られた肝細胞を同一条件で、但し40間培
養し、細胞が球状に集合し浮遊した塊が形成されるので
、これを培養液と共に回収し、低速遠心によって細胞塊
をそれまでの培養液と分離した。この細胞塊を前記した
培養上清と混合してそれぞれ1.5mlずつプライマリ
ア、ファルコン100B、  ファルコン3001 (
ベクトン&ディッキンソン2社製)の3種の351培養
用デイツシユに移植した。1個のデイツシュあたりに1
00個の細胞塊を移植した。これを37℃の5%炭酸ガ
スインキュベーター内で培養して24時間後の細胞の形
態を以下の5種類に分類し、50〜80個の形態を位相
差顕微鏡で観察してその百分率を求めた。対照実験とし
て、培養−L清の代わりに新たなHDMを用いて各容器
で細胞塊を培養した。
The hepatocytes obtained in the same manner were cultured under the same conditions for 40 hours, and the cells aggregated into a spherical shape to form a floating mass, which was recovered together with the culture medium, and the cell mass was separated by low-speed centrifugation. It was separated from the culture solution. This cell mass was mixed with the above-mentioned culture supernatant and 1.5 ml each of Primaria, Falcon 100B, and Falcon 3001 (
The cells were transplanted to 3 types of 351 culture dishes manufactured by Becton & Dickinson. 1 per datesh
00 cell clusters were transplanted. The cells were cultured in a 5% carbon dioxide incubator at 37°C, and after 24 hours, the morphology of the cells was classified into the following five types, and 50 to 80 morphologies were observed using a phase contrast microscope to determine their percentages. . As a control experiment, cell clumps were cultured in each container using fresh HDM instead of Culture-L supernatant.

A:細胞か球状に集合して浮遊したもの。A: Cells aggregated in a spherical shape and suspended.

B:細胞が球状に集合しているが培養容器に付着したも
の。
B: Cells aggregated in a spherical shape but attached to the culture container.

C:球状塊が培養容器表面に接着し一部伸展したもの。C: A spherical mass adheres to the surface of the culture container and partially extends.

D;接着伸展した細胞の中心部が層状を成しているもの
D: The central part of cells that have adhered and extended form a layer.

E:接着伸展した細胞が単層を形成しているもの。E: Cells that have adhered and spread form a monolayer.

表1に示したように未使用のHDMを用いた場合に比較
すると明らかに細胞の形態に差が認められ、長期間の培
養に適したA、Bの形態を肝細胞が保持していることが
わかる。すなわち、今回用いた培養上清にこの様な効果
があるということである。また、この後、1週間以上培
養してもその形態は保持されていた。さらに、電子顕微
鏡により観察すると、細胞内オルガネラも生体内の肝細
胞のそれと等しい形態を保持しており、細胞間の接着斑
や漱少胆管も形成されておりこの点からも形態的に安定
に維持されていると考えられた。
As shown in Table 1, there is a clear difference in cell morphology when compared to when unused HDM is used, indicating that hepatocytes maintain the A and B morphology suitable for long-term culture. I understand. In other words, the culture supernatant used this time has such an effect. Moreover, even after culturing for more than one week, the morphology was maintained. Furthermore, when observed with an electron microscope, the intracellular organelles retain the same morphology as that of in vivo hepatocytes, and intercellular adhesion spots and small bile ducts are also formed, which also shows that the organelles are morphologically stable. considered to be maintained.

表1 実施例2 実施例1と同一条件でファルコン1008デイツシュを
用いて細胞塊の培養を行い、培養後2週間口まで1日当
たりのアルブミンの分泌量を測定し、そのときのデオキ
シリボ核酸の量に対する値を求めた。対照実験としてコ
ラーゲン基質上での単層項五したものを用いて行った。
Table 1 Example 2 A cell mass was cultured using a Falcon 1008 Dish under the same conditions as in Example 1, and the amount of albumin secreted per day was measured for two weeks after the culture, and the amount of deoxyribonucleic acid at that time was measured. I found the value. A control experiment was performed using a monolayer layer on a collagen matrix.

アルブミンの分泌量は20目は1.0μg/μg DN
A7日であって、これが611 [1までに1.5μg
/μg DNA/日に上昇し、2週間1]までこのレベ
ルを保った。一方、単層培養では、20[1に1.0μ
g/μg DNA/日であったものが2週間の間に次第
に減少して、最後は0.15μg/μgl)Nへ/[l
となった。
The amount of albumin secretion is 1.0 μg/μg at 20 eyes DN
A7 days, this is 611 [1.5 μg by 1
/μg DNA/day and remained at this level for up to 2 weeks [1]. On the other hand, in monolayer culture, 1.0μ
g/μg DNA/day gradually decreased over two weeks to 0.15μg/μgl)N/[l
It became.

以上のことから、本発明によると蛋白質分泌能という分
化機能的にも安定した培養系が確立できることがわかる
From the above, it can be seen that according to the present invention, a culture system that is stable in terms of differentiation function such as protein secretion ability can be established.

実施例3 実施例1で槁近上清を得たときと同一条件で培養を行い
、1ケ月培養を行った。培養容器から培養液及び細胞を
吸引除去し、これを用いて肝細胞の培養を行った。尚、
培養液には未使用のHDMを用い、移植した細胞の前処
理や細胞数および培養環境の条件は実施例1に阜じた。
Example 3 Culture was carried out under the same conditions as in Example 1 when the supernatant was obtained, and the culture was carried out for one month. The culture solution and cells were removed by suction from the culture container, and used to culture hepatocytes. still,
Unused HDM was used as the culture medium, and the pretreatment of the transplanted cells, the number of cells, and the culture environment conditions were the same as in Example 1.

培養液は交換せずに1週間培養し、その形態を位相差顕
微鏡で観察した。その結果、移植後1週間にわたって細
胞の球状の塊がそのままの形態を保ち、底面への付着も
極めて軽度であった。
The cells were cultured for one week without replacing the culture solution, and their morphology was observed using a phase contrast microscope. As a result, the spherical mass of cells maintained its shape for one week after transplantation, and attachment to the bottom surface was extremely slight.

Claims (2)

【特許請求の範囲】[Claims] (1)肝臓より分離した肝実質細胞を、陰性荷電を持た
ないプラスチック製の培養容器中で、細胞接着のための
基質及び肝細胞外間質物質を添加せずに、無血清培地を
用いて培養した培養液に肝細胞球状塊を添加して培養す
ることを特徴とする肝細胞の培養方法。
(1) Hepatic parenchymal cells isolated from the liver were cultured in a non-negatively charged plastic culture container using a serum-free medium without the addition of a substrate for cell adhesion or hepatic extracellular interstitial material. A method for culturing hepatocytes, which comprises adding hepatocyte spherules to a cultured medium and culturing them.
(2)肝臓より分離した肝実質細胞を、陰性荷電を持た
ないプラスチック製の培養容器中で、細胞接着のための
基質及び肝細胞外間質物質を添加せずに、無血清培地を
用いて培養した培養容器に肝細胞球状塊を添加して培養
することを特徴とする肝細胞の培養方法。
(2) Hepatic parenchymal cells isolated from the liver were cultured in a non-negatively charged plastic culture container using a serum-free medium without the addition of a substrate for cell adhesion or hepatic extracellular interstitial material. A method for culturing hepatocytes, which comprises adding hepatocyte spherules to a cultured culture vessel and culturing them.
JP63127023A 1988-05-26 1988-05-26 Culture method for hepatic cell Pending JPH01296982A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63127023A JPH01296982A (en) 1988-05-26 1988-05-26 Culture method for hepatic cell

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63127023A JPH01296982A (en) 1988-05-26 1988-05-26 Culture method for hepatic cell

Publications (1)

Publication Number Publication Date
JPH01296982A true JPH01296982A (en) 1989-11-30

Family

ID=14949771

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63127023A Pending JPH01296982A (en) 1988-05-26 1988-05-26 Culture method for hepatic cell

Country Status (1)

Country Link
JP (1) JPH01296982A (en)

Similar Documents

Publication Publication Date Title
Lázaro et al. Establishment, characterization, and long-term maintenance of cultures of human fetal hepatocytes
Cai et al. Development and evaluation of a system of microencapsulation of primary rat hepatocytes
Clement et al. Long-term co-cultures of adult human hepatocytes with rat liver epithelial cells: modulation of albumin secretion and accumulation of extracellular material
JP4146802B2 (en) Dedifferentiated programmable stem cells originating from monocytes and their production and use
TWI740180B (en) Multipotent stem cells from the extrahepatic biliary tree and methods of isolating same
US20180305669A1 (en) Microtissue formation using stem cell-derived human hepatocytes
US8377689B2 (en) EPHA4-positive human adult pancreatic endocrine progenitor cells
TW200902716A (en) Complexes of hyaluronans, other matrix components, hormones and growth factors for maintenance, expansion and differentiation of hepatic cells
Sato et al. A new three-dimensional culture system for hepatocytes using reticulated polyurethane
Brill et al. Expansion conditions for early hepatic progenitor cells from embryonal and neonatal rat livers
RU2333243C2 (en) Dedifferentiated programmed stem cells of monocytic origin, their obtaining and application
CN102282250A (en) Method of differentiating mammalian progenitor cells into insulin producing pancreatic islet cells
WO1997016536A1 (en) Method for ex vivo proliferation and differentiation of adult pancreatic islet cells, media useful therefor and uses thereof
US20090221022A1 (en) Three Dimensional Cell Culture
CN110951686A (en) Hematopoietic stem cell in-vitro amplification culture system and method
JP2004516020A (en) Cell storage
Lee et al. Enhanced liver-specific functions of endothelial cell-covered hepatocyte hetero-spheroids
JPH01296982A (en) Culture method for hepatic cell
Dich et al. Primary cultures of rat hepatocytes
JPH01277486A (en) Method for carrying out spherical culture of lever cell
JPH09313172A (en) Culture of small liver cell
CN116426470B (en) Mesenchymal stem cell serum-free medium and application thereof
CN116396930B (en) Mesenchymal stem cell serum-free medium and application thereof
Sakai et al. Co-cultured hepatocyte-spheroid chip constructed using the microfabrication technique
Yang et al. Effects of degree of cell-cell contact on liver specific functions of rat primary hepatocytes